400-859-2883
Your location:Home >News center >Industry News

Industry News

07-182022

Overview of Triple Negative Breast Cancer…

This article provides an overview of triple negative breast cancer and a summary of FDA-approved therapies.

Overview of Triple Negative Breast Cancer And FDA Approved Therapies
07-072022

Lipid-Based Nanoparticles: Liposomes VS. …

Liposomes and Lipid nanoparticles (LNPs) are similar ─ and both can be effective for drug delivery ─ but are different in composition and function.

Lipid-Based Nanoparticles: Liposomes VS. Lipid nanoparticles (LNPs)
06-232022

Stem Cell Therapy For Diabetes

In recent years, the development of stem cells in China is in full swing, and diabetes, as an important application direction of stem cells, has attracted great attention.

Stem Cell Therapy For Diabetes
06-232022

PROTAC Technology: An Effective Targeted…

PROteolysis TArgeting Chimeras (PROTACs), providing a new way of thought for new drug development.

PROTAC Technology: An Effective Targeted Protein Degrader
06-142022

SGLT2 Inhibitors: Star Hypoglycemic Agent…

On May 14, Henagliflozin, a SGLT2 inhibitor independently developed by Hengrui Pharma was officially launched. This is the first independently developed SGLT2 inhibitor in China. SGLT2 inhibi…

SGLT2 Inhibitors: Star Hypoglycemic Agents
06-092022

Chanlleges & Advances In Oral Peptide…

How to overcome various barriers to oral absorption of peptide drugs and develop oral drug delivery technology with high bioavailability has become a hot spot and a difficult area of research…

Chanlleges & Advances In Oral Peptide Therapeutics
05-242022

ADC Linker - Development and Challenges

The ADC linker molecule has a major influence on the fate of ADCs. The linker connects the antibody and the cytotoxic payload.

ADC Linker - Development and Challenges
05-192022

Overview of Diabetes Treatment Strategies…

According to the ninth edition of the Diabetes Atlas published by the International Diabetes Federation (IDF), the number of people with diabetes worldwide is estimated to be 463 million in 2…

Overview of Diabetes Treatment Strategies
05-132022

mRNA Technology: How To Achieve Targeted …

As a new pharmaceutical technology, mRNA has made breakthroughs in the treatment of infectious diseases and tumors in a short time. At present, one of the major obstacles in clinical mRNA tec…

mRNA Technology: How To Achieve Targeted Delivery to Organs, Cells, Tumors?
05-112022

Lipid Nanoparticles (LNP) for mRNA Drug D…

Lipid Nanoparticle (LNP) is currently the dominant mRNA Drug delivery system.

Lipid Nanoparticles (LNP) for mRNA Drug Delivery